'Traveller's tummy' may be cured by E. Coli patch

Jeremy Laurance
Thursday 12 June 2008 00:00 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

For sufferers of holiday tummy, relief may be at hand. Scientists have developed a vaccine patch that can cut the incidence of traveller's diarrhoea by 75 per cent.

Traveller's diarrhoea lasts on average between four and five days, involves 18 trips to the loo and leaves sufferers dehydrated and debilitated.

The patch, worn on the upper arm, delivers a tiny dose of toxin produced by E. Coli bacteria, the most common cause of diarrhoea, which stimulates the body's immune response. It is applied for a six-hour period three weeks before travel. A "booster" dose is delivered through a second patch applied one week before travel.

A trial using 170 volunteers in America found it significantly reduced the incidence and severity of diarrhoea. Researchers from the IOMAI Corporation in Gaithersburg, Maryland, found 21 per cent of those given a placebo had a moderate to severe attack of diarrhoea, compared with 5 per cent of those who received the vaccine. The results are published in the journal The Lancet.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in